Schrodinger Inc - Asset Resilience Ratio
Schrodinger Inc (SDGR) has an Asset Resilience Ratio of 33.52% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Schrodinger Inc for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how Schrodinger Inc's Asset Resilience Ratio has changed over time. See what is Schrodinger Inc's book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Schrodinger Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Schrodinger Inc worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $219.11 Million | 33.52% |
| Total Liquid Assets | $219.11 Million | 33.52% |
Asset Resilience Insights
- Very High Liquidity: Schrodinger Inc maintains exceptional liquid asset reserves at 33.52% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Schrodinger Inc Industry Peers by Asset Resilience Ratio
Compare Schrodinger Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcidion Group Ltd
AU:ALC |
Health Information Services | 32.45% |
|
DocCheck AG
XETRA:AJ91 |
Health Information Services | 6.71% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 54.64% |
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 48.49% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
|
Oneview Healthcare Plc
AU:ONE |
Health Information Services | 29.71% |
|
Singular Health Group Ltd
AU:SHG |
Health Information Services | 0.15% |
Annual Asset Resilience Ratio for Schrodinger Inc (2017–2024)
The table below shows the annual Asset Resilience Ratio data for Schrodinger Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 24.88% | $204.80 Million | $823.23 Million | -13.44pp |
| 2023-12-31 | 38.32% | $307.69 Million | $802.96 Million | -14.05pp |
| 2022-12-31 | 52.37% | $360.61 Million | $688.59 Million | -7.94pp |
| 2021-12-31 | 60.31% | $456.21 Million | $756.49 Million | +1.29pp |
| 2020-12-31 | 59.01% | $440.39 Million | $746.26 Million | +20.47pp |
| 2019-12-31 | 38.54% | $59.84 Million | $155.27 Million | +33.28pp |
| 2018-12-31 | 5.26% | $6.35 Million | $120.73 Million | -40.21pp |
| 2017-12-31 | 45.47% | $26.38 Million | $58.02 Million | -- |
About Schrodinger Inc
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery … Read more